Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Phase II Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer

Phase II Study of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydrochloroquine as Treatment in Untreated Pancreas Cancer
Conditions:   Untreated Resectable Pancreatic Adenocarcinoma;   Borderline Resectable Pancreatic Adenocarcinoma;   Locally Advanced Pancreatic Adenocarcinoma
Interventions:   Drug: Paclitaxel protein bound;   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Hydroxychloroquine
Sponsor:   HonorHealth Research Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 17, 2020 / by / in
Comments